EssilorLuxottica Acquires PUcore’s Optical Division to Drive Innovation in High-Index Ophthalmic Lenses

Technology development and sustainability at the core of the group's latest strategic move.

EssilorLuxottica has announced the acquisition of the optical division of South Korean company PUcore, which specializes in the development, production, and commercialization of high-index monomers used in ophthalmic lenses—offering thinner, lighter, and more advanced solutions.

The deal strengthens EssilorLuxottica’s research and development capabilities, and includes a research center, a manufacturing facility, and a commercial branch in South Korea.

It also covers the intellectual property rights related to chemical formulations and industrial processes. The goal is twofold: to expand the group’s technology portfolio and improve the long-term sustainability of the supply chain.

“We are pleased to welcome PUcore’s optical division and its teams into our Group,” said Francesco Milleri, Chairman and CEO, and Paul du Saillant, Deputy CEO of EssilorLuxottica.

“This acquisition allows us to strengthen our upstream capabilities in the lens value chain, expand our portfolio of patents, technologies, and expertise, and continue innovating in high-index monomer formulation and production—benefiting both the industry and the environment.”

The transaction is expected to close by 2025, pending regulatory approvals and customary closing conditions.

Once completed, the integration of PUcore’s optical division will enable EssilorLuxottica to exert even greater control over the entire ophthalmic lens value chain, from material formulation to industrialization, with a positive impact across the industry.